Prognostic Significance of Serum PSA Level and Telomerase, VEGF and GLUT-1 Protein Expression for the Biochemical Recurrence in Prostate Cancer Patients after Radical Prostatectomy

Clinical and Genomic Characterization of Low–Prostate-specific Antigen, High-grade Prostate Cancer

(2018) Brandon A. Mahal et al.   EUROPEAN UROLOGY

Validation of a 10-gene molecular signature for predicting biochemical recurrence and clinical metastasis in localized prostate cancer

(2018) Hatem Abou-Ouf et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings

(2018) Rakesh Shiradkar et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Comparison of cell cycle progression score with two immunohistochemical markers (PTEN and Ki-67) for predicting outcome in prostate cancer after radical prostatectomy

(2018) Priscilla Léon et al.   WORLD JOURNAL OF UROLOGY

Metabolomic Prediction of Human Prostate Cancer Aggressiveness: Magnetic Resonance Spectroscopy of Histologically Benign Tissue

(2018) Lindsey A. Vandergrift et al.   Scientific Reports

Overdetection of Recurrence after Radical Prostatectomy: Estimates Based on Patient and Tumor Characteristics

(2014) J. Xia et al.   CLINICAL CANCER RESEARCH

Extra-telomeric Functions of Human Telomerase: Cancer, Mitochondria and Oxidative Stress

(2014) G. Saretzki   CURRENT PHARMACEUTICAL DESIGN

Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study

(2014) Emilie Lalonde et al.   LANCET ONCOLOGY

Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death

(2013) Simeng Wen et al.   CANCER TREATMENT REVIEWS

Differences in the expression of telomerase and prostate-specific membrane antigen in non-advanced prostatic cancer

(2013) Anna Gasinska et al.   FOLIA HISTOCHEMICA ET CYTOBIOLOGICA

Expression of Ki-67 (MIB-1) and GLUT-1 proteins in non-advanced prostatic cancer

(2013) Elzbieta Luczynska et al.   POLISH JOURNAL OF PATHOLOGY

Microvessel density and expression of vascular endothelial growth factor in clinically localized prostate cancer

(2013) Elżbieta Łuczyńska et al.   POLISH JOURNAL OF PATHOLOGY

Diagnostic and prognostic molecular biomarkers for prostate cancer

(2011) Glen Kristiansen   HISTOPATHOLOGY

High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer

(2010) Sarah Minner et al.   PROSTATE

Contemporary Risk Profile of Prostate Cancer in the United States

(2009) Yu-Hsuan Shao et al.   JNCI-Journal of the National Cancer Institute

Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress

(2008) S. Ahmed et al.   JOURNAL OF CELL SCIENCE

Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study

(2008) Roy Vergis et al.   LANCET ONCOLOGY

Wild-type but not mutant androgen receptor inhibits expression of the hTERT telomerase subunit: a novel role of AR mutation for prostate cancer development

(2007) Udo Moehren et al.   FASEB JOURNAL